SCAT Newsletters - City Hospital, Birmingham
Below are some newsletters from Sandwell and West Birmingham NHS Trust, SCaT Team for the latest news.
Clicking on a Newsletter below will download a pdf copy of the newsletter
February 2023 Edition
Below are some newsletters from Sandwell and West Birmingham NHS Trust, SCaT Team for the latest news.
Clicking on a Newsletter below will download a pdf copy of the newsletter
February 2023 Edition
Dr Shivan Pancham, Consultant Haematologist was recognised by Sandwell and West Birmingham NHS Trust (SWB) for the wonderful work she does in promoting research and transformation for the red cell disorders community. Congratulations Dr Pancham!
Click on the following link where you can watch a short YouTube clip of one of SWB's research nurses discussing why this award was so well deserved: https://www.youtube.com/watch?v=YCCl0YbUgAg. You can also read more about the staff recognition event here: https://www.swbh.nhs.uk/media/nhs-heroes-take-home-the-trophies-2/
Click on the following link to be taken to the BBC's website where you can read a news article about Birmingham woman Jenica Leah who has written a series of children's books to help raise awareness of sickle cell: https://www.bbc.co.uk/news/uk-england-birmingham-63129471
Sickle cell patients have begun receiving the first new treatment for the blood disorder in over 20 years.
The inherited condition can cause severe pain and organ failure, often requiring hospital admissions.
Crizanlizumab is given as a monthly infusion and is thought to cut visits to A&E by 40%.
Sickle cell patients have begun receiving the first new treatment for the blood disorder in over 20 years.
A patient who received the treatment at Birmingham City Hospital, having suffered repeated periods of intense pain for decades.
These are called sickle cell crises and are common in people with the condition.
"To have a crisis is pain beyond what you could ever experience," Patient says.
"They give you a scale of one to 10 - but it is way beyond that."
Sickle cell disease causes red blood cells to distort and become sticky, blocking vessels and restricting oxygen supply, which triggers excruciating pain.
Crizanlizumab, a monoclonal antibody, binds to a protein on blood cells, preventing them from clumping.
Sickle cell mostly affects black people.
To read the full article on the BBC website please click this link
Jimi Olaghere thought he would have to wait decades to be freed from his sickle cell disease - but now scientists have engineered his blood to overcome the disease which left him in constant pain.
If you would like to read the full story please click here to be directed to the BBC website